Literature DB >> 20097856

Activation of ExoU phospholipase activity requires specific C-terminal regions.

Katherine M Schmalzer1, Marc A Benson, Dara W Frank.   

Abstract

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that utilizes a type III secretion system to subvert host innate immunity. Of the 4 known effector proteins injected into eukaryotic cells, ExoS and ExoU are cytotoxic. The cytotoxic phenotype of ExoU depends on the enzymatic activity of the patatin-like phospholipase A(2) domain localized to the N-terminal half of the protein. Amino acid residues located within the C-terminal region of ExoU are postulated to be required for trafficking or localization to the plasma membrane of eukaryotic cells. This report describes the characterization of a transposon-based linker insertion library in ExoU. Utilizing an unbiased screening approach and sensitive methods for measuring enzymatic activity, we identified regions of ExoU that are critical for activation of the phospholipase activity by the only known cofactor, SOD1. Insertions at D572 and L618 reduced the rate of substrate cleavage. Enzymatic activity could be restored to almost parental levels when SOD1 concentrations were increased, suggesting that the linker insertion disrupted the interaction between ExoU and SOD1. An enzyme-linked immunosorbent assay (ELISA)-based binding test was developed to measure ExoU-SOD1 binding. These experiments suggest that ExoU activation by SOD1 is hampered by linker insertion. ExoU derivatives harboring minimal phospholipase activity retained biological activity in tissue culture assays. These proteins affected primarily cellular architecture in a manner similar to that of ExoT. Our studies suggest that conformational changes in ExoU are facilitated by SOD1. Importantly, the level of phospholipase activity influences the biological outcome of ExoU intoxication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097856      PMCID: PMC2838045          DOI: 10.1128/JB.00904-09

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  55 in total

1.  ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.

Authors:  V Finck-Barbançon; J Goranson; L Zhu; T Sawa; J P Wiener-Kronish; S M Fleiszig; C Wu; L Mende-Mueller; D W Frank
Journal:  Mol Microbiol       Date:  1997-08       Impact factor: 3.501

2.  Extracellular superoxide dismutase in human tissues and human cell lines.

Authors:  S L Marklund
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.

Authors:  S M Fleiszig; J P Wiener-Kronish; H Miyazaki; V Vallas; K E Mostov; D Kanada; T Sawa; T S Yen; D W Frank
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium.

Authors:  S M Fleiszig; N Efron; G B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-09       Impact factor: 4.799

5.  The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.

Authors:  H Fu; J Coburn; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species.

Authors:  S L Marklund
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Escherichia-Pseudomonas shuttle vectors derived from pUC18/19.

Authors:  H P Schweizer
Journal:  Gene       Date:  1991-01-02       Impact factor: 3.688

8.  Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.

Authors:  T L Yahr; J T Barbieri; D W Frank
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

9.  Arachidonic acid activates NADPH oxidase by a direct, calmodulin-regulated mechanism.

Authors:  P J Hartfield; J M Robinson
Journal:  Prostaglandins Other Lipid Mediat       Date:  1998-05       Impact factor: 3.072

10.  Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes.

Authors:  L Y Chang; J W Slot; H J Geuze; J D Crapo
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  18 in total

1.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

2.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Authors:  David M Anderson; Jimmy B Feix; Andrew L Monroe; Francis C Peterson; Brian F Volkman; Arthur L Haas; Dara W Frank
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

4.  Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Authors:  Marc A Benson; Steven M Komas; Katherine M Schmalzer; Monika S Casey; Dara W Frank; Jimmy B Feix
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

5.  Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Authors:  David M Anderson; Hiromi Sato; Aaron T Dirck; Jimmy B Feix; Dara W Frank
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

6.  Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Authors:  Matthew J Wargo; Maegan J Gross; Sathish Rajamani; Jenna L Allard; Lennart K A Lundblad; Gilman B Allen; Michael L Vasil; Laurie W Leclair; Deborah A Hogan
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

7.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

8.  Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Gregory H Tyson; Alan R Hauser
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy.

Authors:  K Adam Morrow; Cristhiaan D Ochoa; Ron Balczon; Chun Zhou; Laura Cauthen; Mikhail Alexeyev; Katherine M Schmalzer; Dara W Frank; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-04       Impact factor: 5.464

10.  Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.

Authors:  Jimmy B Feix; Samantha Kohn; Maxx H Tessmer; David M Anderson; Dara W Frank
Journal:  Cell Biochem Biophys       Date:  2018-07-25       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.